← Wiki Index / Microbiology & Immunology / Innate Lymphoid Cell
🦠 Microbiology & Immunology

Innate Lymphoid Cell

Innate lymphoid cells (ILCs) are a family of antigen-receptor-negative lymphocytes that lack RAG-rearranged T- or B-cell receptors and act as the innate mucosal counterparts of cytotoxic and helper T cells across Group 1 (NK and ILC1), Group 2 (ILC2), and Group 3 (ILC3 and LTi) lineages.

Innate lymphoid cells (ILCs) are a family of tissue-resident, innate immune lymphocytes that derive from the common lymphoid progenitor (CLP) in bone marrow and fetal liver alongside B and T cells, but lack recombination-activating gene (RAG1/RAG2)-rearranged antigen-specific receptors (expressing neither T-cell receptors [TCR] nor B-cell receptors [BCR]) and lack myeloid/granulocyte/dendritic lineage surface markers (Lineage-negative, Lin−). Discovered across a series of landmark studies between 1975 (natural killer cells), 1997 (lymphoid tissue inducer cells, Mebius et al., 1997), 2008–2009 (RORγt+ NKp46+ mucosal cells, Satoh-Takayama et al., 2008; Sanos et al., 2009), and 2010 (type 2 "nuocytes," "natural helper cells," and "MPPtype2" cells, Moro et al., 2010; Neill et al., 2010; Saenz et al., 2010), and unified into a formal nomenclature by Hergen Spits, David Artis, Marco Colonna, Andreas Diefenbach, James P. Di Santo, Gerard Eberl, Shigeo Koyasu, Richard M. Locksley, Andrew N. J. McKenzie, Reina E. Mebius, Fiona Powrie, and Eric Vivier (2013; Vivier et al., 2018), ILCs function as the innate mirror images of adaptive T lymphocytes. Enriched at mucosal barrier surfaces—including the intestinal lamina propria, bronchial mucosa, dermis, and adipose tissue—ILCs respond within minutes to hours to epithelial alarmins and myeloid cytokines (IL-12, IL-15, IL-18, IL-25, IL-33, TSLP, IL-1β, and IL-23) rather than peptide–MHC complexes, orchestrating early host defense against viruses, intracellular bacteria, helminths, and fungi before adaptive T-cell clones can proliferate.

Developmental Ontogeny: Common Helper Innate Lymphoid Progenitors (CHILP) and Id2

Transcriptional Specification from the Common Lymphoid Progenitor

All innate lymphoid cells and adaptive B/T lymphocytes originate from hematopoietic stem cells via the common lymphoid progenitor (CLP; Lin−IL-7Rα+Flt3+). However, commitment to the innate lymphoid lineage diverges from T- and B-cell development through the silencing of RAG1/RAG2 and the sequential activation of four core transcription factors (Constantinides et al., 2014; Klose et al., 2014; Vivier et al., 2018):

  1. Early Innate Lymphoid Progenitor (EILP) via NFIL3 and TCF-1 (Tcf7): Downstream of the CLP, expression of the basic leucine zipper factor NFIL3 (E4BP4), TOX, and TCF-1 restricts B- and T-cell potential and specifies the α-lymphoid progenitor (αLP) / EILP, which possesses developmental potential for all five mature ILC subsets (including cytotoxic Natural Killer [NK] cells).
  2. Id2-Dependent Suppression of E-Box Proteins: Upregulation of Inhibitor of DNA binding 2 (Id2)—a helix-loop-helix protein that heterodimerizes with and neutralizes the B/T-lineage E-box transcription factors E2A (TCF3) and HEB—blocks adaptive lymphocyte commitment and generates the Common Helper Innate Lymphoid Progenitor (CHILP; Lin−Id2+IL-7Rα+α4β7+), which loses cytotoxic NK-cell potential ( as NK progenitors diverge earlier under Eomesodermin [Eomes]) and gives rise exclusively to all helper-like ILCs (ILC1, ILC2, ILC3, and LTi cells).
  3. Bifurcation of LTi Progenitors and PLZF+ ILC Precursors (ILCp): Within the CHILP compartment, a subset lacking PLZF (Zbtb16) upregulates RORγt (Rorc) directly to form Lymphoid Tissue Inducer (LTi) cells, while the PLZF+ ILC precursor (ILCp) differentiates into mature tissue-resident ILC1, ILC2, and ILC3 subsets depending on local microenvironmental Notch, GATA3, T-bet, and RORγt cues.
ILC Subset (2018 IUIS Nomenclature)Adaptive T-Cell MirrorMaster Transcription Factor(s)Activating Innate Stimuli / AlarminsSignature Effector MoleculesPrimary Physiological Role & Associated Immunopathology
NK Cells (Group 1 Cytotoxic)CD8+ Cytotoxic T Lymphocyte (CTL)Eomes + T-bet (TBX21)Missing-self MHC class I; NKG2D / NKp46 ligands; IL-12, IL-15, IL-18Perforin, Granzyme B, IFN-γ, TNF-αLysis of virus-infected (CMV, herpesviruses) and transformed tumor cells
ILC1 (Group 1 Helper)CD4+ Th1 CellT-bet (TBX21) (Eomes−)IL-12, IL-15, IL-18 (from dendritic cells and macrophages)IFN-γ, TNF-α (low/absent perforin)Defense against intracellular bacteria (Salmonella, C. difficile) and protozoa (Toxoplasma gondii); Crohn's disease
ILC2 (Group 2 Helper)CD4+ Th2 CellGATA3 + RORα + Bcl11bEpithelial alarmins IL-25, IL-33, TSLP; neuropeptide NMU, leukotriene LTD4IL-5, IL-13, IL-9, Amphiregulin (AREG), minimal IL-4Expulsion of gastrointestinal helminths (Nippostrongylus); adipose thermogenesis; allergic asthma & atopic dermatitis
ILC3 (Group 3 Helper, NCR+ & NCR−)CD4+ Th17 / Th22 CellRORγt (RORC) + AhRIL-23, IL-1β (from CX3CR1+ myeloid cells); dietary AhR indolesIL-22, IL-17A, IL-17F, GM-CSF, Lymphotoxin (LTα1β2)Enterocyte RegIIIγ antimicrobial synthesis; clearance of Citrobacter rodentium & Candida albicans; psoriasis & IBD
LTi Cells (Lymphoid Tissue Inducer, Group 3)Fetal / Postnatal OrganogenesisRORγt (RORC) + Id2Retinoic acid; RANKL, IL-7, CXCL13Membrane LTα1β2, TNF-α, IL-17, IL-22Embryonic organogenesis of lymph nodes and Peyer's patches; postnatal cryptopatch → isolated lymphoid follicle maturation

The Five Mature Subsets Across Groups 1, 2, and 3

Group 1: Cytotoxic NK Cells and T-bet+ Helper ILC1s

Group 1 ILCs are unified by expression of the T-box transcription factor T-bet (TBX21) and production of the signature type 1 cytokine interferon-γ (IFN-γ) in response to IL-12, IL-15, and IL-18:

  • Natural Killer (NK) Cells (T-bet+Eomes+CD56+): The innate counterparts of CD8+ cytotoxic T cells. Circulating through blood, spleen, and liver, NK cells integrate inhibitory killer-cell immunoglobulin-like receptors (KIRs in humans, Ly49 in mice, which sense self MHC class I molecules via Klas Kärre's "missing-self" hypothesis) against activating stress receptors (NKG2D, NKp46/NCR1, CD16/FcγRIIIA), releasing perforin and granzyme B to kill virally infected and MHC-I-deficient tumor cells.
  • Helper ILC1s (T-bet+Eomes−CD127+CD49a+): First resolved as a distinct non-cytotoxic, IL-7Rα (CD127)+ lineage by Christoph S. N. Klose, Andreas Diefenbach, et al. (2014), helper ILC1s reside permanently in the intestinal lamina propria, liver, and salivary glands. During early infection with the intracellular protozoan Toxoplasma gondii or the enteric pathogen Clostridioides difficile, lamina propria ILC1s are the primary source of early IFN-γ and TNF-α that recruit Ly6Chi inflammatory monocytes and activate macrophage inducible nitric oxide synthase (iNOS) hours before adaptive Th1 cells arrive.

Group 2: GATA3+ ILC2s, the "Weep and Sweep" Helminth Response, and Neuro-Immune Circuits

Group 2 ILCs (ILC2s; discovered simultaneously in 2010 by Kazuyo Moro & Shigeo Koyasu, Daniel R. Neill & Andrew N. J. McKenzie, and Steven A. Saenz & David Artis) are the innate counterparts of CD4+ Th2 cells, governed by high expression of GATA3, RORα, and Bcl11b and surface expression of the IL-33 receptor (ST2 / IL-1RL1), the IL-25 receptor (IL-17RB), and CRTH2 (prostaglandin D2 receptor 2 in humans):

  1. Tuft-Cell IL-25 and Alarmin IL-33 / TSLP Activation: When parasitic nematodes (Nippostrongylus brasiliensis, Heligmosomoides polygyrus) or allergens breach the intestinal or bronchial epithelium, chemosensory epithelial tuft cells sense helminth succinate via the receptor Sucnr1 and secrete IL-25, while necrotic epithelial cells release nuclear IL-33 and thymic stromal lymphopoietin (TSLP) (von Moltke et al., 2016).
  2. The "Weep and Sweep" Effector Cascade: Activated ILC2s rapidly secrete large quantities of IL-5 and IL-13 (plus IL-9 and the epidermal growth factor receptor ligand amphiregulin [AREG]). IL-5 recruits and sustains eosinophils, while IL-13 acts directly on intestinal stem cells to drive a 10-fold hyperplasia of mucus-secreting goblet cells (Muc2 hypersecretion, the "weep") and stimulates enteric smooth muscle hypercontractility (the "sweep") to expel the worms, while AREG repairs damaged lung and gut epithelium (Monticelli et al., 2011).
  3. Cholinergic Neuropeptide NMU Amplification: As discovered by Henrique Veiga-Fernandes, David Artis, and Richard M. Locksley (Cardoso et al., 2017; Klose et al., 2017), mucosal ILC2s express the receptor NMUR1 for neuromedin U (NMU) released directly by enteric cholinergic neurons upon sensing helminth products—triggering rapid Ca2+/NFAT-driven IL-5 and IL-13 release within minutes, whereas sympathetic β2-adrenergic signaling and calcitonin gene-related peptide (CGRP) restrain runaway ILC2-driven allergic asthma.

Group 3: RORγt+ ILC3s, Enterocyte IL-22 Barrier Defense, and Fetal LTi Cells

Group 3 ILCs require the retinoid-related orphan receptor RORγt (RORC) and the aryl hydrocarbon receptor (AhR), mirroring adaptive Th17 and Th22 cells (Satoh-Takayama et al., 2008; Sonnenberg & Artis, 2015):

  • Lymphoid Tissue Inducer (LTi) Cells (RORγt+CCR6+CD4+/−): During embryogenesis, fetal liver-derived LTi cells migrate to nascent lymph node and Peyer's patch anlagen in response to retinoic acid and CXCL13. LTi cells express membrane lymphotoxin-α1β2 (LTα1β2), which ligates the LTβR on mesenchymal stromal organizer cells to induce VCAM-1, ICAM-1, and chemokines—meaning that mice lacking Rorc or Id2 are born devoid of all lymph nodes and Peyer's patches (Mebius et al., 1997; Eberl et al., 2004)!
  • NCR+ and NCR− Mucosal ILC3s (RORγt+NKp46+/− in mice; NKp44+/− in humans): Activated by IL-23 and IL-1β from lamina propria CX3CR1+ macrophages and sustained by dietary cruciferous/microbial AhR ligands, ILC3s are the dominant constitutive source of interleukin-22 (IL-22) in the mammalian intestine. Because the IL-22 receptor (IL-22R1/IL-10R2) is expressed on non-hematopoietic epithelial and stromal cells (and absent from immune cells), ILC3-derived IL-22 signals selectively to intestinal enterocytes via STAT3 to: (1) stimulate secretion of the bactericidal C-type lectins RegIIIβ and RegIIIγ and S100A8/A9 calprotectin; (2) induce fucosyltransferase 2 (Fut2) to decorate apical mucins with α1,2-fucose that feeds beneficial commensals; and (3) drive Lgr5+ intestinal stem cell proliferation to seal mucosal micro-erosions (Lindemans et al., 2015). Additionally, as discovered by Matthew R. Hepworth, Gregory F. Sonnenberg, et al. (2013), CCR6+ ILC3s express MHC class II without CD80/CD86 co-stimulatory molecules, presenting commensal bacterial antigens to colitogenic CD4+ T cells to induce clonal anergy/deletion and maintain peripheral tolerance toward the human microbiome.

Lineage Plasticity and Clinical Immunopathology

Although defined by distinct master transcription factors, mature mucosal ILCs exhibit remarkable epigenetic plasticity in inflamed tissues (Bernink et al., 2015; Bal et al., 2016):

  • ILC3 ↔ ILC1 Conversion in Crohn's Disease: In the presence of chronic IL-12 and IL-18, protective IL-22–producing RORγt+ ILC3s downregulate RORC, upregulate TBX21 (T-bet), and transdifferentiate into pathogenic IFN-γ–producing "ex-ILC3" ILC1s that accumulate in the inflamed ileum of patients with Crohn's disease; this transition can be reversed back to ILC3s by IL-23, IL-1β, and retinoic acid.
  • ILC2 → ILC1 Conversion in COPD: Similarly, during acute viral exacerbations of chronic obstructive pulmonary disease (COPD) or cigarette-smoke exposure, IL-12 and IL-1β convert lung GATA3+ ILC2s into T-bet+ IFN-γ–secreting ILC1-like cells that amplify emphysematous airway destruction.

Frequently Asked Questions

If innate lymphoid cells lack T-cell receptors, how do they avoid attacking healthy host tissues continuously?

Unlike adaptive T cells, which are gated by peptide–MHC engagement of a rearranged TCR, helper ILCs are gated by spatial sequestration of epithelial alarmins and myeloid cytokines paired with inhibitory neuro-immune receptors. In a healthy barrier, IL-33 is sequestered inside the nucleus of intact epithelial cells (and released only upon necrotic cell lysis), IL-25 is released by tuft cells only upon succinate/helminth detection, and IL-23/IL-1β are secreted by macrophages only upon Toll-like receptor engagement. Furthermore, inhibitory receptors—including KLRG1, PD-1, TIGIT, and β2-adrenergic/CGRP neuropeptide receptors—continuously restrain basal ILC cytokine output until an acute barrier breach occurs.

Why did vertebrates evolve adaptive Th1, Th2, and Th17 T cells if ILC1, ILC2, and ILC3 already perform the same effector programs?

As proposed by Gerard Eberl, Hergen Spits, and Eric Vivier (2015, 2018), the three innate lymphoid effector modules (Group 1/2/3 ILCs—whose transcriptional networks date back to jawless vertebrates such as lampreys) evolved first to provide immediate, local barrier homeostasis and rapid containment of viral, helminth, and bacterial breaches during the critical first 0 to 96 hours of infection. Following the acquisition of the RAG1/RAG2 transposon in jawed vertebrates (~500 Ma), the newly evolved adaptive T-cell system co-opted the pre-existing T-bet, GATA3, and RORγt transcriptional modules, coupling them to somatically rearranged TCRs and clonal memory so that once an infection persists beyond day 5, antigen-specific Th1, Th2, and Th17 clones can expand 10,000-fold and establish lifelong systemic immunological memory.

References

  1. Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., et al. (2010). "Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells." Nature, 463(7280), 540–544. https://doi.org/10.1038/nature08636
  2. Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K., et al. (2010). "Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity." Nature, 464(7293), 1367–1370. https://doi.org/10.1038/nature08900
  3. Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., et al. (2013). "Innate lymphoid cells—a proposal for uniform nomenclature." Nature Reviews Immunology, 13(2), 145–149. https://doi.org/10.1038/nri3365
  4. Hepworth, M. R., Monticelli, L. A., Fung, T. C., Ziegler, C. G., Grunberg, S., Sinha, R., et al. (2013). "Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria." Nature, 498(7452), 113–117. https://doi.org/10.1038/nature12240
  5. Vivier, E., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., et al. (2018). "Innate lymphoid cells: 10 years on." Cell, 174(5), 1054–1066. https://doi.org/10.1016/j.cell.2018.07.017
🧬 Support Open Science
Explore interactive science games on LowKey Games or browse scientific apparel & accessories in the CRV Science Shop.
💡 Spot an inaccuracy or have primary literature to expand this article?
Submit a citation or revision note using your shared CRV Science / LowKey Games profile ID.
Suggest Revision